Atlas Trials

Clinical Trial to Evaluate the Efficacy, Pharmacokinetics (PK) Interactions and Safety of Dolutegravir Plus 2 Nucleoside Reverse Transcriptase Inhibitors (NRTIs) in HIV-1-Infected Solid Organ Transplant Patients

Clinical trial NCT03360682 · COMPLETED

Trial details

NCT number
NCT03360682
Sponsor
Fundacion Clinic per a la Recerca Biomédica
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
HIV-1-infectionSolid Organ Transplant
Start date
2018-04-13
Primary completion
2020-05-21
Enrollment
19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.